Publications by authors named "Jochen Wilke"

Claim this Profile
F
Functional differences between CLL- and ALL-derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL-10 as potential modulatory targets.
Janin Dingfelder, Michael Aigner, Jana Lindacher, Pascal Lukas, Cindy Flamann, Jochen Wilke

Hemasphere· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia.
Jana Lindacher, Anne Hartebrodt, Janin Dingfelder, Pascal Lukas, Laeschkir Würthner, Jochen Wilke

Hemasphere· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Jochen Wilke

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer.
Julia Engel, Vanessa Wieder, Marcus Bauer, Sandy Kaufhold, Kathrin Stückrath, Jochen Wilke

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Frank Griesinger, Martin Sebastian, Wolfgang M Brueckl, Horst-Dieter Hummel, Bastian Jaeschke, Jochen Wilke

JTO Clin Res Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.
Stephane Oudard, Nadine Benhamouda, Bernard Escudier, Patrice Ravel, Thi Tran, Jochen Wilke

Cells· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia.
Sarah Handl, Franziska von Heydebrand, Simon Voelkl, Robert A J Oostendorp, Jochen Wilke

Leuk Lymphoma· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.
Franziska von Heydebrand, Maximilian Fuchs, Meik Kunz, Simon Voelkl, Anita N Kremer, Jochen Wilke

Stem Cells· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Pauline Dürr, Katja Schlichtig, Carolin Kelz, Birgit Deutsch, Renke Maas, Jochen Wilke

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Daniel Heudobler, Christian Schulz, Jürgen R Fischer, Peter Staib, Thomas Wehler, Jochen Wilke

Front Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Norbert Marschner, Jochen Wilke, Daniel Reschke, Florian Kaiser, Claudia Schmoor

J Med Econ· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany.
Peter Dall, Gertrud Lenzen, Thomas Göhler, Christian Lerchenmüller, Gabriele Feisel-Schwickardi, Jochen Wilke

J Geriatr Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Jalid Sehouli, Dirk Stengel, Philipp Harter, Christian Kurzeder, Antje Belau, Jochen Wilke

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation.
Albrecht Reichle, Jochen Grassinger, Klaus Bross, Jochen Wilke, Thomas Suedhoff

Biomark Insights· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis